165 related articles for article (PubMed ID: 35301003)
1. Injectable self-crosslinking hydrogels based on hyaluronic acid as vitreous substitutes.
Yu S; Wang S; Xia L; Hu H; Zou M; Jiang Z; Chi J; Zhang Y; Li H; Yang C; Liu W; Han B
Int J Biol Macromol; 2022 May; 208():159-171. PubMed ID: 35301003
[TBL] [Abstract][Full Text] [Related]
2. A self-healing and injectable hydrogel based on water-soluble chitosan and hyaluronic acid for vitreous substitute.
Wang S; Chi J; Jiang Z; Hu H; Yang C; Liu W; Han B
Carbohydr Polym; 2021 Mar; 256():117519. PubMed ID: 33483040
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of two different thiol-modified crosslinked hyaluronate formulations as vitreous replacement compared to silicone oil in a model of retinal detachment.
Schnichels S; Schneider N; Hohenadl C; Hurst J; Schatz A; Januschowski K; Spitzer MS
PLoS One; 2017; 12(3):e0172895. PubMed ID: 28248989
[TBL] [Abstract][Full Text] [Related]
4. The self-crosslinking smart hyaluronic acid hydrogels as injectable three-dimensional scaffolds for cells culture.
Bian S; He M; Sui J; Cai H; Sun Y; Liang J; Fan Y; Zhang X
Colloids Surf B Biointerfaces; 2016 Apr; 140():392-402. PubMed ID: 26780252
[TBL] [Abstract][Full Text] [Related]
5. A highly transparent tri-polymer complex
Yadav I; Purohit SD; Singh H; Das N; Roy P; Mishra NC
Biomed Mater; 2021 Oct; 16(6):. PubMed ID: 34525462
[TBL] [Abstract][Full Text] [Related]
6. A cross-linked hyaluronic acid hydrogel (Healaflow(®)) as a novel vitreous substitute.
Barth H; Crafoord S; Andréasson S; Ghosh F
Graefes Arch Clin Exp Ophthalmol; 2016 Apr; 254(4):697-703. PubMed ID: 26743755
[TBL] [Abstract][Full Text] [Related]
7. Characterization of silk-hyaluronic acid composite hydrogels towards vitreous humor substitutes.
Raia NR; Jia D; Ghezzi CE; Muthukumar M; Kaplan DL
Biomaterials; 2020 Mar; 233():119729. PubMed ID: 31927250
[TBL] [Abstract][Full Text] [Related]
8. An injectable oxidated hyaluronic acid/adipic acid dihydrazide hydrogel as a vitreous substitute.
Su WY; Chen KH; Chen YC; Lee YH; Tseng CL; Lin FH
J Biomater Sci Polym Ed; 2011; 22(13):1777-97. PubMed ID: 20843434
[TBL] [Abstract][Full Text] [Related]
9. Inflammatory responses after vitrectomy with vitreous substitutes in a rabbit model.
Barth H; Crafoord S; Arnér K; Ghosh F
Graefes Arch Clin Exp Ophthalmol; 2019 Apr; 257(4):769-783. PubMed ID: 30656473
[TBL] [Abstract][Full Text] [Related]
10. Injectable self-crosslinking HA-SH/Col I blend hydrogels for in vitro construction of engineered cartilage.
Chen Y; Sui J; Wang Q; Yin Y; Liu J; Wang Q; Han X; Sun Y; Fan Y; Zhang X
Carbohydr Polym; 2018 Jun; 190():57-66. PubMed ID: 29628260
[TBL] [Abstract][Full Text] [Related]
11. Rabbit study of an in situ forming hydrogel vitreous substitute.
Swindle-Reilly KE; Shah M; Hamilton PD; Eskin TA; Kaushal S; Ravi N
Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4840-6. PubMed ID: 19324846
[TBL] [Abstract][Full Text] [Related]
12. Biomimetic hydrogel with tunable mechanical properties for vitreous substitutes.
Santhanam S; Liang J; Struckhoff J; Hamilton PD; Ravi N
Acta Biomater; 2016 Oct; 43():327-337. PubMed ID: 27481290
[TBL] [Abstract][Full Text] [Related]
13. Ex vivo biophysical characterization of a hydrogel-based artificial vitreous substitute.
Januschowski K; Schnichels S; Hurst J; Hohenadl C; Reither C; Rickmann A; Pohl L; Bartz-Schmidt KU; Spitzer MS
PLoS One; 2019; 14(1):e0209217. PubMed ID: 30615640
[TBL] [Abstract][Full Text] [Related]
14. Injectable in situ cross-linking hyaluronan hydrogel for easier removal of posterior vitreous cortex in vitrectomy.
Hisatomi T; Tachibana T; Mori K; Ishikawa K; Ishibashi T; Sonoda KH; Uchio E; Watanabe I; Suzuki K; Iida M
Jpn J Ophthalmol; 2024 Mar; 68(2):146-156. PubMed ID: 38311687
[TBL] [Abstract][Full Text] [Related]
15. The cross-linked biopolymer hyaluronic acid as an artificial vitreous substitute.
Schramm C; Spitzer MS; Henke-Fahle S; Steinmetz G; Januschowski K; Heiduschka P; Geis-Gerstorfer J; Biedermann T; Bartz-Schmidt KU; Szurman P
Invest Ophthalmol Vis Sci; 2012 Feb; 53(2):613-21. PubMed ID: 22199245
[TBL] [Abstract][Full Text] [Related]
16. Stable oxime-crosslinked hyaluronan-based hydrogel as a biomimetic vitreous substitute.
Baker AEG; Cui H; Ballios BG; Ing S; Yan P; Wolfer J; Wright T; Dang M; Gan NY; Cooke MJ; Ortín-Martínez A; Wallace VA; van der Kooy D; Devenyi R; Shoichet MS
Biomaterials; 2021 Apr; 271():120750. PubMed ID: 33725584
[TBL] [Abstract][Full Text] [Related]
17. Meropenem loaded 4-arm-polyethylene-succinimidyl-carboxymethyl ester and hyaluronic acid based bacterial resistant hydrogel.
Yadav I; Purohit SD; Singh H; Das NS; Ghosh C; Roy P; Mishra NC
Int J Biol Macromol; 2023 Apr; 235():123842. PubMed ID: 36854369
[TBL] [Abstract][Full Text] [Related]
18. Translation of hyaluronic acid-based vitreous substitutes towards current regulations for medical devices.
Schulz A; Germann A; Heinz WR; Engelhard M; Menz H; Rickmann A; Meiser I; Wien S; Wagner S; Januschowski K; Szurman P
Acta Ophthalmol; 2023 Jun; 101(4):422-432. PubMed ID: 36457299
[TBL] [Abstract][Full Text] [Related]
19. Vitreous substitutes: An overview of the properties, importance, and development.
Yadav I; Purohit SD; Singh H; Bhushan S; Yadav MK; Velpandian T; Chawla R; Hazra S; Mishra NC
J Biomed Mater Res B Appl Biomater; 2021 Aug; 109(8):1156-1176. PubMed ID: 33319466
[TBL] [Abstract][Full Text] [Related]
20. Safety and performance assessment of hyaluronic acid-based vitreous substitutes in patients with phthisis bulbi.
Schulz A; Wakili P; Januschowski K; Heinz WR; Engelhard M; Menz H; Szurman P
Acta Ophthalmol; 2023 Sep; 101(6):687-695. PubMed ID: 36912796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
